3 ms·
> because of the enormous cost of FDA approval. Then one would expect some other country, with better costs for regulatory approval, to be a hotbed of medical
by RestlessMind 6y ago
> because of the enormous cost of FDA approval.
Then one would expect some other country, with better costs for regulatory approval, to be a hotbed of medical innovations. Are there any examples?
- WalterBright 6y agoGood question. I expect many countries don't have a regulatory approval process at all, and simply rubberstamp FDA approval. Nevertheless, medical tourism is a thing to get non-FDA approved treatments. For example, "60 Minutes" ran a segment a few months back on a Cuban cancer treatment unavailable in the US due to the FDA, and I've read about a Thai hip replacement procedure that is not FDA approved, but lots of Americans go there for it. I also don't know what US law has to say about a US company developing a drug for non-FDA use outside the US. Certainly, it would not be a good public relations move, and may be a legal and liability minefield. Would you be willing to risk your investment capital in such a venture?